Mainz Biomed N.V. (NASDAQ: MYNZ) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT MAINZ BIOMED N.V.

Mainz Biomed N.V. (NASDAQ: MYNZ)
Listen to this Section


$7.25
+0.2500 ( -11.59% ) 433.7K

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Market Data


Open $7.25
Previous Close $7.00
Volume 433.7K
Market Cap $17.22M
Day Range $7.02 - $8.42
52 Week Range $3.65 - $48.80
Shares Outstanding 2.22M
Change % -11.59%
Net Change ▲ 0.2500
Insider Ownership N/A
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2021
Country Germany
Under Writer Boustead Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Form 6-K 1 Jan 14, 2025
6-k Form 6-K 3 Dec 16, 2024
424b3 Other 6 Dec 16, 2024
6-k Form 6-K 2 Dec 13, 2024
effect Other 1 Dec 12, 2024
f-1/a Other 6 Dec 11, 2024
corresp Comment letters 1 Dec 11, 2024
corresp Comment letters 1 Dec 11, 2024
f-1/a Other 19 Dec 09, 2024
f-1/a Other 4 Dec 09, 2024

Latest News


× Before browsing our site, please accept our cookies policy